Where to Buy Semaglutide Compound: A Comprehensive Guide

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide is not something you buy — it is something a licensed pharmacy prepares for you against an individual prescription written by a licensed prescriber. The FDA’s guidance is direct on this point: patients should obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy. Anything sold without that chain — research chemicals, peptide vials marketed "not for human consumption", offshore sellers — sits outside the framework entirely, and the agency has published a specific list of warning signs for exactly this market.

The Legal Structure Behind a Legitimate Source

Section 503A of the Federal Food, Drug, and Cosmetic Act sets the conditions under which a licensed pharmacist in a state-licensed pharmacy may compound a drug product. Compounding occurs for an identified individual patient based on a valid prescription order, and the bulk drug substances used must comply with an applicable United States Pharmacopeia or National Formulary monograph where one exists, be manufactured by an FDA-registered establishment, and be accompanied by valid certificates of analysis.

The same section prohibits compounding regularly or in inordinate amounts any drug product that is essentially a copy of a commercially available drug product. That constraint is part of why the compounded GLP-1 landscape changed after the FDA resolved the semaglutide and tirzepatide shortages in 2025.

Oversight is layered. The FDA states that state boards of pharmacy generally have primary responsibility for day-to-day oversight of state-licensed pharmacies not registered as outsourcing facilities, while the FDA conducts surveillance and for-cause inspections.

The FDA’s Own Red Flags

The agency lists concrete warning signs for consumers evaluating a telehealth service or online pharmacy in this category: claims that the compounded drug is the same as an FDA-approved drug; deep discounts or prices that seem too good to be true; medicine that looks different from what you previously received or from what was pictured; packaging that is broken, damaged or lacks instructions for use; no requirement for screening and a prescription by a licensed doctor before providing medicine; no licensed doctor available to answer questions after delivery; spelling errors on the label; and pharmacy names or addresses that appear fraudulent.

Those are not vague heuristics. The FDA has documented fraudulent compounded semaglutide and tirzepatide products carrying false label information, including labels naming compounding pharmacies that do not exist and labels naming licensed pharmacies that did not compound the product.

Shipping and Storage Are Part of the Product

Injectable GLP-1 drugs require refrigeration as indicated in their package inserts. The FDA has received complaints that certain compounded GLP-1 drugs arrived warm or with inadequate ice packs to maintain recommended storage temperatures, and recommends that patients not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration, because this can affect the drug’s quality.

This is a practical evaluation criterion for a mail-order source. How the shipment arrives is observable evidence about the operation behind it, and it is one of the few quality signals a patient can assess directly.

What Cannot Lawfully Be Compounded

The FDA states that retatrutide and cagrilintide cannot be used in compounding under federal law, that they are not components of FDA-approved drugs, and that they have not been found safe and effective for any condition. The agency has warned telehealth companies for marketing unapproved drugs such as retatrutide, including direct-to-consumer marketing, and has warned API distributors for selling retatrutide to compounders.

A source offering these molecules is offering something the agency has said cannot lawfully be compounded. That is a decisive signal about the operation, not a grey area.

Salt Forms and What to Ask

The FDA has stated that some semaglutide products sold by compounders may be salt forms, including semaglutide sodium and semaglutide acetate, and that these salt forms are different active ingredients than those used in the approved drugs. The agency does not have information on whether these salts share the same chemical and pharmacologic properties.

That makes one question worth asking directly: which form of the active ingredient does the pharmacy use, and can it provide the certificate of analysis for the lot dispensed. A pharmacy operating within section 503A holds that document as a legal requirement.

The Framing That Keeps You Out of Trouble

Compounded semaglutide is not a generic of Wegovy or Ozempic. The FDA distinguishes the two categories explicitly: a generic drug is approved under section 505(j) of the Act and must establish therapeutic equivalence to a brand-name drug, while a compounded drug is not FDA-approved and the agency does not verify its safety, effectiveness or quality before marketing.

The agency’s position on when the category is appropriate is equally explicit: compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. That determination is a clinical one, made by a prescriber who knows your situation, and it is the first question to settle — before any question about where.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I buy compounded semaglutide without a prescription?

No legitimate route exists. Compounding under section 503A occurs for an identified individual patient based on a valid prescription order, and the FDA advises patients to obtain a prescription from their doctor and fill it at a state-licensed pharmacy. Sellers offering vials without a prescription, including products labelled for research use only, are outside that framework entirely.

How do I check whether a pharmacy is legitimate?

Verify state licensure through the relevant state board of pharmacy, which the FDA identifies as holding primary day-to-day oversight of state-licensed pharmacies not registered as outsourcing facilities. Then apply the agency’s published red flags, including claims that a compounded drug is the same as an approved one, absent prescriber screening, and no licensed doctor reachable after delivery.

What should I do if my shipment arrives warm?

The FDA recommends that patients not use any injectable GLP-1 drug that arrives warm or with insufficient refrigeration, because this can affect the drug’s quality. Injectable GLP-1 drugs require refrigeration as indicated in their package inserts, and the agency has received complaints about compounded products arriving warm or with inadequate ice packs. Contact the dispensing pharmacy.

Is compounded semaglutide the same as Wegovy?

No. The FDA states that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before marketing, and that compounded drugs are not the same as generic drugs, which must establish therapeutic equivalence under section 505(j). The agency lists claiming equivalence to an approved drug as a consumer warning sign.

Why do some sellers offer retatrutide?

They should not. The FDA states that retatrutide and cagrilintide cannot be used in compounding under federal law, are not components of FDA-approved drugs, and have not been found safe and effective for any condition. The agency has warned telehealth companies for marketing retatrutide and warned ingredient distributors for selling it to compounders.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.